Raleigh, NC — There’s a lot of talk about artificial intelligence these days. A company with offices in Durham and elsewhere in the country is using AI to help advance scientific research.
Dotmatics is a scientific research and development software company committed to connecting science and data through cloud-based platforms and applications.
Alister Campbell, vice president and global head of science and technology at the company, said AI will affect the pharmaceutical industry in many ways, including the cost of bringing medicines to market.
“As you can imagine, developing a new drug takes a very long time, typically decades, and costs a lot of money, between $2 billion and $6 billion,” he said. Told. to reduce its cost. Using AI can help scientists reduce that time by identifying targets and maximizing success. ”
Campbell says clinical trial failure rates are so high that other costs add up.
“So what we want to do is help customers reduce their failure rates so they don’t spend money on research that can fail,” he said.
Campbell says AI can help determine which drugs are most likely to succeed.
Some scientists have recently expressed concern about AI’s destructive capabilities.
“What’s really important is seeing how AI is being used in research. The quality of the AI is as good as the data that feeds it,” Campbell said.
